Founded in 2003, FlowMedic Ltd. is developing a new generation of lightweight, portable medical devices to treat circulatory disorders, which integrate the company’s unique, patented intermittent compression technology.
For the millions who suffer from Peripheral Arterial Disorder (PAD), Deep Vein Thrombosis (DVT) and other circulatory disorders, FlowMedic’s breakthrough devices provide effective management in enhancing circulation, without ongoing medical supervision. They are non-invasive, safe and easy to use, in or outside the hospital.
A Paradigm Shift
FlowMedic’s technology represents a paradigm shift in treating circulatory diseases of the lower limbs. Conventional treatments to improve blood flow in the lower limbs currently involve surgical means, pharmacological treatment, and the use of Intermittent Pneumatic Compression (IPC) devices. FlowMedic’s products, which feature a compact design, light weight and simple operation, encourage use and compliance.
The Management Team
From its inception, FlowMedic has been managed by a seasoned team of professionals, all of whom bring extensive biomedical experience to the company.
FlowMedic is owned by private investors, including industry veterans Shlomo Ben-Haim and Lew Pell, who leverage an unparalleled operational, strategic and financial network within the biomedical industry.
For more information about FlowMedic, please contact us at: email@example.com